Our Mission

Our mission is to revolutionize medicine by creating therapies that cure patients of their disease.

We leverage our drug design and operational expertise to create novel covalent small molecules to treat serious and life-threatening diseases. All of our molecules are invented and created in-house. They are highly selective, targeted medicines, that address key mechanisms of our patient’s disease progression. We have built an R&D engine that has so far produced three novel, covalent inhibitor programs that are currently in preclinical and clinical development. Our team is engaged in all phases of drug discovery and development, including target selection, small molecule design, and preclinical and clinical studies to develop our innovative medicines.